Standard
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. / Vilsbøll, Tina; Rosenstock, J; Yki-Järvinen, H; Cefalu, W T; Chen, Y; Luo, E; Musser, B; Andryuk, P J; Ling, Y; Vendersbo, Rene Kaufman; Amatruda, J M; Engel, S S; Katz, L.
I:
Diabetes, Obesity and Metabolism, Bind 12, Nr. 2, 01.02.2010, s. 167-77.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Vilsbøll, T, Rosenstock, J, Yki-Järvinen, H, Cefalu, WT, Chen, Y, Luo, E, Musser, B, Andryuk, PJ, Ling, Y, Vendersbo, RK, Amatruda, JM, Engel, SS & Katz, L 2010, '
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes',
Diabetes, Obesity and Metabolism, bind 12, nr. 2, s. 167-77.
https://doi.org/10.1111/j.1463-1326.2009.01173.x
APA
Vilsbøll, T., Rosenstock, J., Yki-Järvinen, H., Cefalu, W. T., Chen, Y., Luo, E., Musser, B., Andryuk, P. J., Ling, Y., Vendersbo, R. K., Amatruda, J. M., Engel, S. S., & Katz, L. (2010).
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes.
Diabetes, Obesity and Metabolism,
12(2), 167-77.
https://doi.org/10.1111/j.1463-1326.2009.01173.x
Vancouver
Vilsbøll T, Rosenstock J, Yki-Järvinen H, Cefalu WT, Chen Y, Luo E o.a.
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes.
Diabetes, Obesity and Metabolism. 2010 feb. 1;12(2):167-77.
https://doi.org/10.1111/j.1463-1326.2009.01173.x
Author
Vilsbøll, Tina ; Rosenstock, J ; Yki-Järvinen, H ; Cefalu, W T ; Chen, Y ; Luo, E ; Musser, B ; Andryuk, P J ; Ling, Y ; Vendersbo, Rene Kaufman ; Amatruda, J M ; Engel, S S ; Katz, L. / Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. I: Diabetes, Obesity and Metabolism. 2010 ; Bind 12, Nr. 2. s. 167-77.
Bibtex
@article{3fd7f3134a7741318628186a2a79f2b3,
title = "Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes",
abstract = "To evaluate the efficacy and tolerability of sitagliptin when added to insulin therapy alone or in combination with metformin in patients with type 2 diabetes.",
author = "Tina Vilsb{\o}ll and J Rosenstock and H Yki-J{\"a}rvinen and Cefalu, {W T} and Y Chen and E Luo and B Musser and Andryuk, {P J} and Y Ling and Vendersbo, {Rene Kaufman} and Amatruda, {J M} and Engel, {S S} and L Katz",
year = "2010",
month = feb,
day = "1",
doi = "http://dx.doi.org/10.1111/j.1463-1326.2009.01173.x",
language = "English",
volume = "12",
pages = "167--77",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "2",
}
RIS
TY - JOUR
T1 - Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
AU - Vilsbøll, Tina
AU - Rosenstock, J
AU - Yki-Järvinen, H
AU - Cefalu, W T
AU - Chen, Y
AU - Luo, E
AU - Musser, B
AU - Andryuk, P J
AU - Ling, Y
AU - Vendersbo, Rene Kaufman
AU - Amatruda, J M
AU - Engel, S S
AU - Katz, L
PY - 2010/2/1
Y1 - 2010/2/1
N2 - To evaluate the efficacy and tolerability of sitagliptin when added to insulin therapy alone or in combination with metformin in patients with type 2 diabetes.
AB - To evaluate the efficacy and tolerability of sitagliptin when added to insulin therapy alone or in combination with metformin in patients with type 2 diabetes.
U2 - http://dx.doi.org/10.1111/j.1463-1326.2009.01173.x
DO - http://dx.doi.org/10.1111/j.1463-1326.2009.01173.x
M3 - Journal article
VL - 12
SP - 167
EP - 177
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
SN - 1462-8902
IS - 2
ER -
